Cogent Biosciences, Inc. SEC filings COGT

Cogent Biosciences, Inc. has 616 filings in SEC EDGAR's recent list, going back to Oct 20, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Cogent Biosciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
8-K Current report
Material agreement
Sep 2, 2026 Sep 1, 2026
4 Insider transaction Aug 31, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
8-K Current report
Other events
Aug 10, 2026 Aug 10, 2026
424B5 Prospectus supplement Aug 10, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
4 Insider transaction May 21, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 9, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Mar 31, 2026 —
4 Insider transaction Mar 31, 2026 Mar 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
S-8 Employee stock plan registration Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 22, 2026 Jan 22, 2026
144 Notice of proposed sale Jan 22, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 22, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Dec 30, 2025 Dec 26, 2025
4 Insider transaction Dec 30, 2025 Dec 26, 2025
4 Insider transaction Dec 30, 2025 Dec 26, 2025
4 Insider transaction Dec 30, 2025 Dec 26, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 8, 2025 Dec 6, 2025
8-K Current report
Material agreement, New debt
Nov 18, 2025 Nov 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Material agreement, Other events
Nov 13, 2025 Nov 11, 2025
424B5 Prospectus supplement Nov 12, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
FWP Free writing prospectus Nov 12, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 10, 2025
S-3ASR Automatic shelf registration Nov 7, 2025 —
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
8-K Current report
Material agreement, New debt
Sep 11, 2025 Sep 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 14, 2025 —
4 Insider transaction Jul 14, 2025 Jul 10, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 11, 2025 —
8-K Current report
Material agreement, Results of operations
Jul 10, 2025 Jul 7, 2025
424B5 Prospectus supplement Jul 9, 2025 —
424B5 Prospectus supplement Jul 8, 2025 —
8-K Current report
Other events
Jul 7, 2025 Jul 7, 2025
4 Insider transaction Jul 2, 2025 Jul 1, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Jun 5, 2025 Jun 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
EFFECT Filing May 9, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
424B5 Prospectus supplement May 6, 2025 —
POS AM Filing May 6, 2025 —
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 11, 2025 —
PRE 14A Preliminary proxy statement Apr 11, 2025 Jun 4, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 15, 2025 Jan 14, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
8-K Current report
Other events
Dec 9, 2024 Dec 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
4 Insider transaction Oct 2, 2024 Oct 1, 2024
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 2, 2024 Jul 1, 2024
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
4 Insider transaction Jun 13, 2024 Jun 5, 2024
SC 13D/A Amended ownership over 5% (active) Jun 13, 2024 —
4 Insider transaction Jun 12, 2024 Jun 10, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 5, 2024 Jun 5, 2024
4 Insider transaction May 29, 2024 May 25, 2024
3 Initial insider ownership May 29, 2024 May 25, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 5, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Jun 5, 2024
EFFECT Filing Apr 10, 2024 —
CORRESP Letter to the SEC Apr 8, 2024 —
UPLOAD Letter from the SEC Apr 5, 2024 —
4 Insider transaction Apr 2, 2024 Apr 1, 2024
SC 13D/A Amended ownership over 5% (active) Apr 1, 2024 —
4 Insider transaction Apr 1, 2024 Mar 28, 2024
S-3 Shelf registration Mar 29, 2024 —
SC 13D/A Amended ownership over 5% (active) Mar 27, 2024 —
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Mar 22, 2024 Mar 21, 2024
S-8 Employee stock plan registration Feb 26, 2024 —
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
SC 13D/A Amended ownership over 5% (active) Feb 16, 2024 —
4 Insider transaction Feb 16, 2024 Feb 16, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
Feb 14, 2024 Feb 13, 2024
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 5, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
4 Insider transaction Jan 25, 2024 Jan 23, 2024
4 Insider transaction Jan 25, 2024 Jan 23, 2024
4 Insider transaction Jan 25, 2024 Jan 23, 2024
4 Insider transaction Jan 25, 2024 Jan 23, 2024
4 Insider transaction Jan 25, 2024 Jan 23, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
8-K Current report
Other events
Dec 11, 2023 Dec 9, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
4 Insider transaction Oct 3, 2023 Oct 2, 2023
4 Insider transaction Oct 3, 2023 Oct 2, 2023
S-8 Employee stock plan registration Aug 8, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
COGT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Large accelerated filer
SEC CIK
1622229
Former names
Unum Therapeutics Inc. (until Oct 5, 2020); Unum Therapeutics, Inc. (until Mar 30, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.